Skip to main content
Clinical Trials/NCT04570618
NCT04570618CompletedNot Applicable

Early Prediction of Sepsis in Hospitalized Patients Using a Machine Learning Algorithm, a Randomized Clinical Validation Trial.

AlgoDx1 site in 1 country320 target enrollmentStarted: December 1, 2020Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
320
Locations
1
Primary Endpoint
Validate the prognostic accuracy of the algorithm at predicting sepsis.

Study Overview

Brief Summary

In this clinical trial a novel Medical Device Software will be validated prospectively. The software incorporates a machine learning algorithm capable of predicting sepsis by using routine clinical variables in adult patients at Intensive Care Units.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Diagnostic
Masking
Triple (Participant, Care Provider, Investigator)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Adult patient (age ≥18 years).
  • •Patient is admitted to the ICU during the recruitment period of the trial.

Exclusion Criteria

  • •Patient is participating in another interventional clinical trial which, as judged by the investigator, could potentially impact variables used by the sepsis prediction algorithm or has participated in such interventional clinical trial within the last 30 days.
  • •Patient is known to be pregnant.
  • •Death is deemed imminent and inevitable, at the investigator's discretion.
  • •Patient has, due to chronic reduced mental capacity, been assessed by the investigator as incapable of making an informed decision
  • •Patient has previously been enrolled in this trial.

Arms & Interventions

Standard of Care

Sham Comparator

Subjects are monitored for potential development of sepsis according to the local established clinical management guidelines.

Intervention: Blinded AlgoDx Sepsis Prediction Algorithm (Other)

Standard of Care + AlgoDx Sepsis Prediction Algorithm

Experimental

Subjects are monitored for potential development of sepsis according to the local established clinical management guidelines, and sepsis prediction algorithm alerts are unblinded to clinical staff.

Intervention: Unblinded AlgoDx Sepsis Prediction Algorithm (Device)

Outcomes

Primary Outcomes

Validate the prognostic accuracy of the algorithm at predicting sepsis.

Time Frame: Up to 30 days (ICU hospitalization period)

In order to clinically validate the sepsis prediction performance the following endpoints have been selected: * accuracy, * specificity, and * sensitivity of the AlgoDx Sepsis Prediction Algorithm in the SoC group (not possible to assess these in the SoC + Algorithm cohort).

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
AlgoDx
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials